Item\ue000 11.
\ue000
Executive\ue000 Compensation
\ue000
46
Item\ue000 12.
\ue000
Security\ue000 Ownership\ue000 of\ue000 Certain\ue000 Beneficial\ue000 Owners\ue000 and\ue000 Management\ue000 and\ue000 Related\ue000 Stockholder\ue000 Matters
\ue000
46
Item\ue000 13.
\ue000
Certain\ue000 Relationships,\ue000 Related\ue000 Transactions,\ue000 and\ue000 Director\ue000 Independence
\ue000
47
Item\ue000 14.
\ue000
Principal\ue000 Accountant\ue000 Fees\ue000 and\ue000 Services
\ue000
47
PART\ue000 IV
Item\ue000 15.
\ue000
Exhibits\ue000 and\ue000 Financial\ue000 Statement\ue000 Schedules
\ue000
48
\ue000
Reports\ue000 of\ue000 Independent\ue000 Registered\ue000 Public\ue000 Accounting\ue000 Firm
\ue000
F-1
OTHER
Signatures
\ue000
S-1
2
Table\ue000 of\ue000 Contents
PART\ue000 I
ITEM\ue000 1.\ue000\ue000\ue000\ue000 BUSINESS
\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000This\ue000 Annual\ue000 Report\ue000 on\ue000 Form\ue000 10-K\ue000 contains\ue000 forward-looking\ue000 statements.\ue000 The\ue000 forward-looking\ue000 statements\ue000 are\ue000 contained\ue000 principally\ue000 in
the\ue000 sections\ue000 entitled\ue000 "Risk\ue000 Factors,"\ue000 "Management's\ue000 Discussion\ue000 and\ue000 Analysis\ue000 of\ue000 Financial\ue000 Condition\ue000 and\ue000 Results\ue000 of\ue000 Operations"\ue000 and
"Business."\ue000 These\ue000 statements\ue000 involve\ue000 known\ue000 and\ue000 unknown\ue000 risks,\ue000 uncertainties\ue000 and\ue000 other\ue000 factors\ue000 which\ue000 may\ue000 cause\ue000 our\ue000 actual\ue000 results,
p
erformance\ue000 or\ue000 achievements\ue000 to\ue000 be\ue000 materially\ue000 different\ue000 from\ue000 any\ue000 future\ue000 results,\ue000 performances\ue000 or\ue000 achievements\ue000 expressed\ue000 or\ue000 implied\ue000 by\ue000 the
f
orward-looking\ue000 statements.\ue000 Forward-looking\ue000 statements\ue000 include,\ue000 but\ue000 are\ue000 not\ue000 limited\ue000 to,\ue000 statements\ue000 about:
\u2022
the\ue000 extent\ue000 and\ue000 timing\ue000 of\ue000 future\ue000 revenues;
\u2022
the\ue000 size\ue000 or\ue000 growth\ue000 of\ue000 our\ue000 market\ue000 or\ue000 market-\ue000 share;
\u2022
the\ue000 opportunity\ue000 presented\ue000 by\ue000 new\ue000 products\ue000 or\ue000 emerging\ue000 markets;
\u2022
the\ue000 operating\ue000 margins\ue000 or\ue000 earnings\ue000 per\ue000 share\ue000 goals\ue000 we\ue000 may\ue000 set;
\u2022
our\ue000 ability\ue000 to\ue000 protect\ue000 our\ue000 intellectual\ue000 property\ue000 and\ue000 operate\ue000 our\ue000 business\ue000 without\ue000 infringing\ue000 upon\ue000 the\ue000 intellectual\ue000 property
rights\ue000 of\ue000 others;\ue000 and
\u2022
our\ue000 estimates\ue000 regarding\ue000 the\ue000 sufficiency\ue000 of\ue000 our\ue000 cash\ue000 resources.
\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000In\ue000 some\ue000 cases,\ue000 you\ue000 can\ue000 identify\ue000 forward-looking\ue000 statements\ue000 by\ue000 terms\ue000 such\ue000 as\ue000 "anticipates,"\ue000 "believes,"\ue000 "could,"\ue000 "estimates,"\ue000 "expects,"
"intends,"\ue000 "may,"\ue000 "plans,"\ue000 "potential,"\ue000 "predicts,"\ue000 "projects,"\ue000 "should,"\ue000 "will,"\ue000 "would"\ue000 and\ue000 similar\ue000 expressions\ue000 intended\ue000 to\ue000 identify
f
orward-looking\ue000 statements.\ue000 Forward-looking\ue000 statements\ue000 reflect\ue000 our\ue000 current\ue000 views\ue000 with\ue000 respect\ue000 to\ue000 future\ue000 events,\ue000 are\ue000 based\ue000 on\ue000 assumptions
and\ue000 are\ue000 subject\ue000 to\ue000 risks\ue000 and\ue000 uncertainties.\ue000 We\ue000 discuss\ue000 many\ue000 of\ue000 these\ue000 risks\ue000 in\ue000 this\ue000 Annual\ue000 Report\ue000 on\ue000 Form\ue000 10-K\ue000 in\ue000 greater\ue000 detail\ue000 in\ue000 the
section\ue000 entitled\ue000 "Risk\ue000 Factors"\ue000 under\ue000 Part\ue000 I,\ue000 Item\ue000 1A\ue000 below.\ue000 Given\ue000 these\ue000 uncertainties,\ue000 you\ue000 should\ue000 not\ue000 place\ue000 undue\ue000 reliance\ue000 on\ue000 these
f
orward-looking\ue000 statements.\ue000 Also,\ue000 forward-looking\ue000 statements\ue000 represent\ue000 our\ue000 estimates\ue000 and\ue000 assumptions\ue000 only\ue000 as\ue000 of\ue000 the\ue000 date\ue000 of\ue000 this\ue000 Annual
Report\ue000 on\ue000 Form\ue000 10-K.\ue000 You\ue000 should\ue000 read\ue000 this\ue000 Annual\ue000 Report\ue000 on\ue000 Form\ue000 10-K\ue000 and\ue000 the\ue000 documents\ue000 that\ue000 we\ue000 reference\ue000 in\ue000 this\ue000 Annual\ue000 Report\ue000 on
Form\ue000 10-K\ue000 and\ue000 have\ue000 filed\ue000 as\ue000 exhibits,\ue000 completely\ue000 and\ue000 with\ue000 the\ue000 understanding\ue000 that\ue000 our\ue000 actual\ue000 future\ue000 results\ue000 may\ue000 be\ue000 materially\ue000 different\ue000 from
what\ue000 we\ue000 expect.\ue000 All\ue000 references\ue000 in\ue000 this\ue000 report\ue000 to\ue000 "Omnicell,\ue000 Inc.,"\ue000 "Omnicell,"\ue000 "our,"\ue000 "us,"\ue000 "we,"\ue000 or\ue000 the\ue000 "Company"\ue000 collectively\ue000 refer\ue000 to
Omnicell,\ue000 Inc.,\ue000 a\ue000 Delaware\ue000 corporation,\ue000 and\ue000 its\ue000 subsidiaries.
\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000Except\ue000 as\ue000 required\ue000 by\ue000 law,\ue000 we\ue000 assume\ue000 no\ue000 obligation\ue000 to\ue000 update\ue000 any\ue000 forward-\ue000 looking\ue000 statements\ue000 publicly,\ue000 or\ue000 to\ue000 update\ue000 the\ue000 reasons
actual\ue000 results\ue000 could\ue000 differ\ue000 materially\ue000 from\ue000 those\ue000 anticipated\ue000 in\ue000 any\ue000 forward-looking\ue000 statements,\ue000 even\ue000 if\ue000 new\ue000 information\ue000 becomes\ue000 available
in\ue000 the\ue000 future.
\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000We\ue000 own\ue000 various\ue000 trademarks,\ue000 copyrights\ue000 and\ue000 trade\ue000 names\ue000 used\ue000 in\ue000 our\ue000 business,\ue000 including\ue000 the\ue000 following:\ue000 Executive\ue000 Advisor\u2122,
OmniRx\u00ae,\ue000 SafetyMed\u00ae,\ue000 SafetyStock\u00ae,\ue000 \u00ae,\ue000 vSuite\u2122\ue000 ,\ue000 SecureVault\u00ae,\ue000 WorkflowRx\u2122,\ue000 Omnicell\u00ae,\ue000 the\ue000 Omnicell\ue000 logo,\ue000 OmniCenter\u00ae,
OmniLinkRx\u00ae,\ue000 DecisionCenter\u00ae,\ue000 MedCache\u00ae,\ue000 ScanReq\u00ae,\ue000 Sure-Med\u00ae,\ue000 BCX\ue000 Technology\u00ae,\ue000 Rio\u00ae\ue000 and\ue000 the\ue000 Rio\ue000 logo,\ue000 Freedom\u00ae,\ue000 Liberty\u00ae,
Alliance\u00ae\ue000 and\ue000 Allegiance\u00ae.\ue000 This\ue000 report\ue000 also\ue000 includes\ue000 other\ue000 trademarks,\ue000 service\ue000 marks\ue000 and\ue000 trade\ue000 names\ue000 of\ue000 other\ue000 companies.\ue000 All\ue000 other\ue000 trade
names\ue000 used\ue000 in\ue000 this\ue000 report\ue000 are\ue000 trademarks\ue000 of\ue000 their\ue000 respective\ue000 holders.
Leave a Comment